Biohaven Ltd.
(NYSE: BHVN)

Biohaven Ltd. is a global clinical stage biopharmaceutical company, which engages in the discovery, development, and commercialization of therapies for people with neurological and neuropsychiatric diseases. The company was founded on May 2, 2022 and is headquartered in New Haven, CT.

9.400

-0.205 (-2.13%)
Range 9.290 - 9.820   (5.71%)
Open 9.675
Previous Close 9.605
Bid Price 29.420
Bid Volume -
Ask Price 29.440
Ask Volume -
Volume 962,521
Value -
Remark
Delayed prices. Updated at 06 Dec 2025 00:06.
Data powered by
View All Events

Loading Chart...

Please login to view stock data and analysis